David Fogel News

FDA Approves Endari for Sickle Cell Disease

The US Food and Drug Administration has approved an L-glutamine oral powder (Endari) that reduces oxidant damage to red blood cells for treatment of sickle cell disease. Compared to placebo, Endari reduced the frequency of sickle cell crises by 25% and...

read more

Interview with Olin Hyde, CEO of LeadCrunch, Inc.

Olin Hyde is the CEO of LeadCrunch, Inc. Based in San Diego, LeadCrunch offers an artificial intelligence platform for generating business-to-business (B2B) leads. Olin received a masters degree from UCSD in advanced studies on systems engineering and has been active...

read more

May 11, 1997

Today's an important day in my personal history. Two decades go by in a blink: 20 years ago today, I was in Maui, working on an evolutionary neural network program for breast cancer detection with Dr. Gene Wasson of Maui Memorial Hospital. 20 years ago today, as...

read more